Announcements Call for applications by The Migration Health South Asia Network for skill & capacity development training workshop to be held in 6-9 April 2020   |   Open Letter: Stop the war on Syria’s hospitals

A study of warning letters issued to clinical investigators and institutional review boards by the United States Food and Drug Administration

NJ Gogtay, BM Doshi, U Thatte

DOI: 10.20529/IJME.2011.082


Abstract

Background: Warning letters (WLs) issued by the US FDA (United States Food and Drug Administration) mention the nature of violations by clinical investigators and institutional review boards (IRBS) and can help as training tools.

Full Text

HTML PDF

Keywords

N/A

Refbacks

There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US